Fundraising Fox

Neogene Therapeutics

New York, US · Founded 2018 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

CL
Carsten Linnemann, PhDExecutive Officer, Director, Promoter
DM
David M. TanenDirector, Promoter
FC
Fei ChenDirector
AN
Antonius N.M. SchumacherDirector
HK
Helen KimDirector

Investors · 3

Jeito CapitalParis
SynconaLondonvia Elisa Petris · board
Vida VenturesreportedLos Angelesvia Rajul Jain · board

Reported raises · per SEC filings

Form D private placements
▶$110MraisedSep 2020 · 63 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Antonius N.M. SchumacherDirector
  • Rachel MearsDirector
  • Carsten Linnemann, PhDExecutive Officer, Director, Promoter
  • Katherine WoodDirector
  • David TanenDirector, Promoter
  • Caroline StoutDirector
  • Franz HumerDirector
  • Rajul JainDirector
  • Elisa PetrisDirector
Offering amount
$110M
Amount sold
$110M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedMay 2019 · 42 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carsten Linnemann, PhDExecutive Officer, Director, Promoter
  • David M. TanenDirector, Promoter
  • Fei ChenDirector
  • Antonius N.M. SchumacherDirector
  • Helen KimDirector
Offering amount
$15M
Amount sold
$15M
First sale
May 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.